Agoracom Blog

#HADO: The Amazing Ways Augmented Reality #AR Is Changing Sport – SPONSOR: Imagine AR $IP.ca $SEV.ca $VST.ca $YDX.ca $NTAR.ca

Posted by AGORACOM-JC at 8:49 AM on Friday, June 26th, 2020

SPONSOR: Imagine AR Inc. (IP:CSE) (IPNFF:OTCQB) is an Augmented Reality platform that allows businesses to easily launch AR campaigns. Clients Include: NBA Sacramento Kings, Mall of America, AT&T Shape and The Basketball Hall of Fame. The company recently announced partnership with Engaged Nation, an award winning leader in digital engagement marketing for casinos in addition to a collaboration with Music Superstar Flo Rida Learn More.

http://www.smallcapepicenter.com/imagine%20ar%20squre.jpg

HADO: The Amazing Ways Augmented Reality Is Changing Sport

  • Now that Japanese start-up Meleap created the world’s first physical e-sport called HADO, gamers have a way to be active while competing in the digital world
  • HADO is an entirely new experience the company calls techno sports that uses augmented reality (AR) tech and motion sensors without requiring the player to be tethered to a gaming system, controllers, or cables

By: Bernard Marr Contributor

Now that Japanese start-up Meleap created the world’s first physical e-sport called HADO, gamers have a way to be active while competing in the digital world. HADO is an entirely new experience the company calls techno sports that uses augmented reality (AR) tech and motion sensors without requiring the player to be tethered to a gaming system, controllers, or cables. The company has three AR offerings, including HADO Augmented Sport (Player vs. Player), HADO Monster Battle, and HADO Shoot; they will soon add HADO Kart.

HADO: The Amazing Ways Augmented Reality Is Changing Sport

First Experience to Merge Physical Athletics with AR Technology

In HADO Augmented Sport, you can see how physical the game can be. It resembles dodgeball with players competing in an arena and flipping and bending to avoid being hit by the opposing team’s energy balls. Competitors can play 1v1, 2v2, or 3v3. Each team stays on one side of the court. The goal is to hit the other team with as many energy balls as possible to drain them of their “lives” and get points during a timed event.

Players can defend themselves with shields and barriers. If the shields get hit, they will weaken and ultimately need to be recharged. If you remember playing dodgeball, there is a lot of ducking and diving in HADO, just as there is in the traditional dodgeball game. Quick reflexes and coordination are necessary to avoid being hit. Players also have the option to alter their play characteristics to become more defensive (shields get stronger, but a slower recharge time for attacks) or offensive (quick recharge time after attacks, but shields are weaker). In addition to shield thickness and recharge speed, players can alter the bullet size. These adjustments can allow for different players on the same team to play different strategic roles in the competition.

AR of HADO

The digital experience is enabled by an AR device that players wear on their heads and a motion sensor the size of a smartphone worn on the wrist or forearm. Players are able to move unrestricted in the real environment while interacting with the digital items they can see through the AR headset. This is not a sport played in your living room, but in 60+ arenas in 15 countries that give ample space for the competition similar to other physical sports such as volleyball and basketball. AR tech is also lighter weight, so players can dive and move without feeling weighed down. The possibilities allowed through AR make applications for HADO’s e-sport virtually unlimited.

Physical Fitness with HADO

HADO requires players who are physically agile and have gaming skills as well. Players who succeed at the game will be in constant motion while diving, bending, and squatting to evade the energy balls hurled by the other team. When players shoot energy balls, they use a punching motion. Players must have great hand-eye coordination and be adept at blocking from a variety of angles. There are VR games such as Sparc and Audioshield that can help players with hand-eye coordination training required to be good at HADO.

Global Expansion

HADO has held several competitions and events in Asia, including the HADO World Cup tournament where the world’s top players compete for a cash prize and bragging rights as the HADO World Champions. There are plans to expand globally by 2020. Currently, 600,000 users have experienced HADO sports.

HADO is launching a pro AR league in Japan this year as well. Tournaments are planned every week and will award a cash prize to the winners. The first official season of the pro league begins in the third quarter of 2019.

As this new concept of e-sports gains popularity, a HADO arena might open near you, where you will be able to compete with other players locally to see what it’s all about. Until then, you can watch YouTube to see players in action.

Not only did Meleap make many childhood dreams come true with the creation of HADO and by bringing virtual and physical realms together, but they proved that AR technology and athletic sports can be combined for an entirely new experience. It will be interesting to watch as others apply these concepts to other sports competitions and use cases in a variety of industries.

Source: https://www.forbes.com/sites/bernardmarr/2019/10/23/hado-the-amazing-ways-augmented-reality-is-changing-sport/#19465cde1b33

Tags: , , , , , ,
Posted in Featured, Imagine AR | Comments Off on #HADO: The Amazing Ways Augmented Reality #AR Is Changing Sport – SPONSOR: Imagine AR $IP.ca $SEV.ca $VST.ca $YDX.ca $NTAR.ca

Hollister Biosciences Inc. $HOLL.ca and Allied Corp. sign Definitive Agreement for Distribution of Products Under Veteran Based Brand: Tactical Relief™ $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 7:12 AM on Friday, June 26th, 2020
  • Announced definitive agreement with Allied Corp. to manufacture and distribute throughout California products targeted at veterans and first responders under the brand Tactical Relief ™
  • The first products to be manufactured will feature products that are recognized for their medicinal properties in the treatment of Post Traumatic Stress Disorder (PTSD)

VANCOUVER, British Columbia, June 26, 2020 — Hollister Biosciences Inc. (CSE: HOLL, FRANKFURT: HOB) (the “Company” or “Hollister”) is pleased to announce that further to the press release dated February 7th, 2020, through it’s subsidiary, Hollister Cannabis Co.  has on June 22nd, 2020 signed a definitive agreement (the “Agreement”) to bring to market with Allied Corp. (“Allied”) a pipeline of products that are targeted towards helping veterans and first responders. These products will be brought to market under the brand Tactical Relief™, a veteran-founded hemp-based CBD oil brand owned by Allied Corp. (OTCQB: ALID).

Branded under Tactical Relief™, the first products to be manufactured will feature products that are recognized for their medicinal properties in the treatment of Post Traumatic Stress Disorder (PTSD). True to Hollister’s mission, the products will be crafted in small, artisanal batches for optimal quality and made from premium California-grown cannabis.

Under the terms of the Agreement, Allied will contribute the Tactical Relief™ brand support including use of trademark, artwork, logos and package design for a series of products. On an ongoing basis, Allied will be financially responsible for all marketing design and support. Hollister will be responsible for all aspects of production and procurement of underlying materials. Hollister will also be responsible for all costs associated with distribution and sales support.  All production of cannabis products will take place under Hollister’s supervision and licenses. Allied and Hollister will further explore the development and marketing of additional products, as well as expanding into additional regions within the United States over the coming years.

The new Tactical Relief™ products will be distributed exclusively by Hollister’s distribution partner, Indus Holdings Inc. (CSE: INDS), and is anticipated to be in retail locations throughout California within quarter three of 2020. An estimated 5% of net profits from all sales will be donated to charity.  The remaining revenue generated from the sale of the products will be shared 60:40 between Hollister and Allied.

“This partnership is one that unites two powerful companies in the cannabis space with one common mission: to help veterans and first responders change the way they manage PTSD and TBI. This is a huge shift that has to happen nationwide. This partnership is the start of that shift,” said Adam Smith, VP Natural Health at Allied Corp.

Carl Saling, Hollister’s CEO stated: “We are thrilled to be working with Allied Corp. to bring much needed relief to our amazing veterans and 1st responders with PTSD and other ailments. This is a very important mission for Hollister to be able to have a huge impact on our veteran’s lives.”

About the Tactical Relief™  Brand

Led by a Green Beret and trainer of law enforcement, the Tactical Relief™ brand creates, promotes and sells high quality and patriotic CBD oils throughout the country. Allied’s CBD oils are full spectrum and are currently made from the highest quality hemp grown in Kentucky. Adam Smith (VP of Natural Health for Allied Corp.) is a Green Beret with nearly 17 years in service and experienced firsthand how CBD can help veterans and active-duty (military and first responders) ease their physical and mental stress due to post traumatic stress disorder and traumatic brain injury. Tactical Relief™ is on a mission to end the stigma around hemp and cannabis products, and to provide relief to as many service members as possible.

Website: https://tacticalrelief.com/

About Allied Corp.

Allied Corp. is an international medical cannabis production company with a mission to address today’s medical issues with a primary focus on Post Traumatic Stress Disorder in veterans and first responders. Allied helps those who have served by researching, developing and producing targeted cannabinoid health solutions for those who need them. Allied Corp. uses an evidence-informed scientific approach to make this mission possible, through cutting-edge pharmaceutical research and development, innovative plant-based production and unique development of therapeutic products.

For more information on Allied Corp., visit www.allied.health

Investor Relations for Allied:
[email protected]
1-877-255-4337

About Hollister Biosciences Inc.

Hollister Biosciences Inc. is a California based vertically integrated cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality California-grown cannabis and hemp products. Hollister uses a vertically integrated, high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Cannabis Co. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products. Our wholly owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker.”

Website: www.hollistercannabisco.com

HOLLISTER BIOSCIENCES INC.:

Company Contact:

[email protected]
Tel: 604-961-0296

Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com

Tags: , , , ,
Posted in All Recent Posts, Featured, Hollister Biosciences | Comments Off on Hollister Biosciences Inc. $HOLL.ca and Allied Corp. sign Definitive Agreement for Distribution of Products Under Veteran Based Brand: Tactical Relief™ $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

TransCanna $TCAN.ca Closes Non-Brokered Warrant Financing $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 6:04 PM on Thursday, June 25th, 2020
tcan-square
  • Issued 5,000,000 warrants in a non-brokered private placement at a price of $0.05 per warrant for gross proceeds of $250,000
  • There were no finders’ fees payable on this private placement

Vancouver, British Columbia–(June 25, 2020) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company“) has issued 5,000,000 warrants in a non-brokered private placement at a price of $0.05 per warrant for gross proceeds of $250,000. There were no finders’ fees payable on this private placement.

The private placement is subject to the approval of the Canadian Securities Exchange (“CSE”) and the securities will be subject to a four-month hold period under securities laws. The Company intends to use the net proceeds from the private placement for working capital purposes.

Each warrant entitles the holder to purchase one common share of the Company, at an exercise price of $1.00 per share, for a period of two years from the date of issuance. The warrants are subject to an acceleration right that allows the Company to give notice of an earlier expiry date if the Company’s share price on the CSE (or such other stock exchange the Company’s shares may be trading on is equal to or greater than $1.30 for a period of 20 consecutive trading days.

The Company did not file a material change report more than 21 days before the expected closing of the private placement as the details of the private placement and the participation therein by related parties of the company were not settled until shortly prior to closing and the company wished to close on an expedited basis for sound business reasons and in a time frame consistent with usual market practices for transactions of this nature.

The Company also announces that it has granted 100,000 stock options to a consultant. The stock options are exercisable for a period of 3 years at an exercise price of $1.00. The stock options are being granted pursuant to the terms of the Company’s stock option plan and are subject to regulatory approval.

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a California based, Canadian listed, company building Cannabis-focused brands for the California lifestyle, through its wholly-owned California subsidiaries.

For further information, please visit the Company’s website at www.transcanna.com or email the Company at [email protected].

Bob Blink, CEO

604-349-3011

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF ANY SECURITIES DESCRIBED HEREIN

Tags: , , , , ,
Posted in TransCanna Holdings Inc. | Comments Off on TransCanna $TCAN.ca Closes Non-Brokered Warrant Financing $CGC $ACB $APH $CRON.ca $OGI.ca

#Covid19 Impact on #Mhealth Applications Market is Estimated to Reach USD 100.2 billion by 2023 – SPONSOR: CardioComm Solutions $EKG.ca $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 5:42 PM on Thursday, June 25th, 2020

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

Covid19 Impact on mHealth Applications Market is Estimated to Reach USD 100.2 billion by 2023

  • As per Market Research Future (MRFR), the global mHealth applications market is expected to reach USD 100.2 billion from 2017 to 2023
  • Global mHealth applications market is primarily driven by the increasing adoption of advanced technologies in healthcare sector and the need to reduce long waiting periods for specialists to access healthcare facilities

mHealth is one of the most advanced and disruptive trends in the healthcare sector that has been expanding at an exceptional rate over the last few years. mHealth changes the way traditional medical practices take place and creates a path for the future of healthcare. mHealth helps to track and manage health-related practices by using technologies such as Bluetooth, mobile network (GSM/ GPRS/3G/4 G), and Wi-Fi. Data collected by mHealth devices, such as mobile phones, tablets, laptops, and tablets, help medical professionals, consumers, and other users.

mHealth Applications Market Dynamics

The global mHealth applications market is primarily driven by the increasing adoption of advanced technologies in healthcare sector and the need to reduce long waiting periods for specialists to access healthcare facilities. The availability of mobile applications for users is experiencing rapid growth, particularly in healthcare applications that help consumers manage their illnesses, well-being, and chronic conditions. This increased role of patients, coupled with the increasing importance of keeping up-to-date information about their own health decisions, has contributed to an increase in the global adoption of mHealth applications.

The healthcare industry has moved towards a value-based care model, with mHealth becoming a widespread trend due to the advent of technologies such as remote monitoring, electronic medical records, and other communication platforms. The rising prevalence of disorders such as diabetes, hypertension, cancer, and obesity, as well as raising awareness of wellness and other preventive measures among patients, are expected to fuel the growth of the mHealth application industry.

The introduction of wearable devices from Fitbit, Apple, and Xiaomi have a positive impact on the market. Market growth appears to be positive, with increasing investment in wearable technology start-ups. These start-ups focus on categories of mHealth, such as personal safety, women’s health, and hydration monitoring, which promise exciting market prospects.

mHealth Applications Market Segmentation

The global market for mHealth applications has been segmented based on type, which includes monitoring applications, education & awareness, healthcare management, diagnosis & treatment, wellness & prevention, and others. The monitoring application segment had the largest market share of approximately 53.8% in 2016.

mHealth Applications Market Regional Analysis

Region-wise,the global mHealth applications market has been segmented into Europe, North America, Asia Pacific, and Middle East & Africa.

In 2016, Europe had the highest market share of 31.7% in the global market for mHealth applications, taking into account the regional market scenario.

The Asia Pacific is the second-largest and fastest-growing market in the global market for mHealth applications. APAC is forecast to rise at 33.7% CAGR in 2017-2023. Many Asian countries are adopting digital health strategies to manage healthcare delivery and deliver better outcomes. For example, the Digital India program aims to improve IT services to empower healthcare professionals. These initiatives are expected to make the Asia Pacific the fastest-growing segment in the forecast period.

North America is one of the leaders in the field of mhealth and is only behind the APAC. North America is estimated to cross USD 28762.1 million by 2023.

The Middle East and Africa were valued at USD 1334.9 in 2016 and is expected to rise at a steady pace over the forecast period.

Source: https://www.medgadget.com/2020/06/covid19-impact-on-mhealth-applications-market-is-estimated-to-reach-usd-100-2-billion-by-2023-size-share-clinical-health-data-stress-management-advance-technology-global-growth-factors-and-demand.html

Tags: , , , , , ,
Posted in CardioComm Solutions | Comments Off on #Covid19 Impact on #Mhealth Applications Market is Estimated to Reach USD 100.2 billion by 2023 – SPONSOR: CardioComm Solutions $EKG.ca $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

David Beckham Invests in #Esports with London-based Start-up Guild – SPONSOR: Esports Entertainment Group $GMBL $DKNG $PENN $GAN $ESPO $AESE $EGLX.ca $BRAG.ca $FDM.ca

Posted by AGORACOM-JC at 4:34 PM on Thursday, June 25th, 2020

SPONSOR: Esports Entertainment Group (GMBL:NASDAQ) – Millions of people from around the world tune in to watch teams of video game players compete with each other. In first quarter 2020, YouTube reported 1.1 billion hours watched, an increase of 13% when compared to fourth quarter 2019. Wagering on Esports is projected to hit $23 BILLION this year although that number will likely be eclipsed due to the recent pandemic. Esports Entertainment Group is the next generation online gambling company designed for the purpose of facilitating as much of this wagering as possible.  LEARN MORE.

David Beckham Invests in Esports with London-based Start-up Guild

  • Former England soccer captain David Beckham is moving into the virtual world as co-owner of London-based start-up Guild Esports.
  • Guild said in a statement on Thursday that it will launch player academies and run teams in various esports arenas including Rocket League, EA Sports, FIFA and Fortnite.

“We have a vision to set a new standard, supporting these players into the future,” said Beckham, who is also co-owner of Major League Soccer’s Inter Miami.

“We are committed to nurturing and encouraging youth talent through our academy systems and I am looking forward to helping our Guild Esports team grow,” added the 45-year-old.

The Financial Times reported that Beckham was taking a significant minority stake in Guild through DB Ventures, his personal investment vehicle, and would be the second biggest shareholder.

It said Guild Esports was seeking a valuation of around 100 million pounds ($124.42 million) following a 25 million pound fundraising.

“David will be instrumental in helping shape the coaching programme implemented at our academies and we welcome his valuable mentoring as well as the inspiration he gives the younger generation of athletes,” said Guild executive chairman Carleton Curtis.

Esports has enjoyed a boom during the global COVID-19 lockdown.

According to analytics platform Newzoo, the global esports market will generate revenues of $1.1 billion in 2020 and $1.56 billion by 2023.

Source: https://www.news18.com/news/football/david-beckham-invests-in-esports-with-london-based-start-up-guild-2687447.html

Tags: , , , , , ,
Posted in All Recent Posts, Esports Entertainment Group, Esports Entertainment Group Inc., eSports Investing | Comments Off on David Beckham Invests in #Esports with London-based Start-up Guild – SPONSOR: Esports Entertainment Group $GMBL $DKNG $PENN $GAN $ESPO $AESE $EGLX.ca $BRAG.ca $FDM.ca

CLIENT FEATURE: TransCanna Holdings $TCAN.ca Developing the Largest Multi-Purpose Cannabis Facility in California $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 4:12 PM on Thursday, June 25th, 2020
tcan-square

(CSE: TCAN) (FSE: TH8)

Why TransCanna?

  • $2M CAD Revenue April 2020
  • $24.6M CAD Revenue Run Rate solely from TransCanna test facility
  • $90M Annual Revenue expected from first full year upon completion of 196,000 Sq Ft Daly facility Q3 2021
  • Daly facility will be one of the largest cannabis facilities in California
  • Recently acquired two California companies,
    • High-end award winning edible producer Soldaze
    • Premium indoor cultivator and distributor Lyfted Farms
  • Lyfted Farms products sold in select Cookies Locations – The most recognizable name in high-end Cannabis.
  • 2019 California Cannabis sales over $3B, industry currently fragmented
  • Direct to dispensary model, cutting out the middleman
  • Announced an Inventory and Product Agreement  with Cali Plug UHCC for its highly anticipated inaugural retail location.
    • Cali Plug was founded in 2006 and is a significant influencer in the cannabis space, with approximately 200,000 Instagram followers (@caliplug)
  • Entered MOU with major agriculture firm KeyPlex, to create and market high quality bio-pesticides,
    • bio-fungicides, and fertilizers with micronutrients specifically created for the cannabis industry

WATCH OUR RECENT INTERVIEW

FULL DISCLOSURE: TransCanna Holdings is an advertising client of AGORA Internet Relations Corp.

Tags: , , , , , ,
Posted in AGORACOM Client Feature, TransCanna Holdings Inc. | Comments Off on CLIENT FEATURE: TransCanna Holdings $TCAN.ca Developing the Largest Multi-Purpose Cannabis Facility in California $CGC $ACB $APH $CRON.ca $OGI.ca

Military Invests $27M To Develop New Class Of Psychedelics Drugs SPONSOR: MOTA Ventures $MOTA.ca $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 4:05 PM on Thursday, June 25th, 2020

SPONSOR: Mota Ventures Corp is an established natural health products company focused in the CBD and psychedelic medicine sectors. Through their powerful eCommerce business, Mota is a leading direct-to-consumer provider of a wide range of natural health products throughout the United States and Europe. Click Here for More Info

The successful use of controlled substances such as ketamine and psilocybin mushrooms to treat mental health issues like depression and anxiety has ushered in a new era of interest in psychedelic drugs. But for researchers and clinicians eager to expand such therapies, an obvious question remains: Does treatment with psychedelics necessarily require a psychedelic experience?

An international research team hopes to answer that question by researching and developing a new class of drugs that offers the same fast-acting mental health benefits as traditional psychedelics without the disorienting, sometimes uncomfortable effects of a full-blown trip. Funded by $26.9 million from the U.S. Department of Defense’s Defense Advanced Research Projects Agency (DARPA), a new project announced this month “aims to create new medications to effectively and rapidly treat depression, anxiety, and substance abuse without major side effects,” according to a University of North Carolina (UNC) School of Medicine press release.

“Although drugs like ketamine and potentially psilocybin have rapid antidepressant actions, their hallucinogenic, addictive, and disorienting side effects make their clinical use limited,” said Brian L. Roth, a professor of pharmacology at UNC School of Medicine and the research project’s leader. “Our team has developed innovative methods and technologies to overcome these limitations with the goal of creating better medications to treat these neuropsychiatric conditions.”

Research into the possible therapeutic effects of currently illicit drugs such as ketamine, psilocybin, MDMA and others has expanded tremendously during the past decade. Nonprofit groups such as the Multidisciplinary Association for Psychedelic Studies have led the way, with university researchers and drugmakers entering the mix more recently.

In September of last year, Johns Hopkins University announced the launch of the nation’s first-ever psychedelic research center, a $17-million project to study the use of psychedelics to treat conditions such as opioid use disorder, Alzheimer’s disease, depression, anxiety and post-traumatic stress disorder (PTSD).

Government interest in psychedelic drugs has also grown. Also in September, DARPA, a federal agency that exists to support the development of emerging technologies for use by the U.S. military, announced its Focused Pharma program, meant to develop drugs “that work quickly and deliver lasting remedies for conditions such as chronic depression and post-traumatic stress.”

While that DARPA announcement didn’t mention specific substances or even use the word “psychedelics,” it referred to “certain Schedule 1 controlled drugs that engage serotonin receptors” and that have “significant side effects, including hallucination.”

The press release for the new DARPA-funded project, lead by Roth at UNC, mentions ketamine and psilocybin specifically. The team will use both biological modeling and sophisticated computational approaches in an effort to design fast-acting drugs inspired by psychedelics but free from what researchers call “disabling side effects.”

“Depression, anxiety, and substance abuse affect large segments of the population,” Roth said. “Rapidly acting drugs with antidepressant, anti-anxiety, and anti-addictive potential devoid of disabling side effects do not exist, not even as experimental compounds for use in animals. Creating such compounds would change the way we treat millions of people around the world suffering from these serious and life-threatening conditions.”

At DARPA, Dr. Tristan McClure-Begley, Focused Pharma’s program manager, said last fall that the agency’s interest in developing such drugs is due to the country’s large number of veterans with PTSD and other mental health conditions.

“It is research we need to undertake given the scale of the mental health crisis our veterans face,” he said in September, “and if it works, the payoff is a completely new, safe, and effective therapeutic option that transforms complex and previously intractable mental conditions into something more acutely treatable.”

Along with Roth at UNC Chapel Hill, the newly announced research project includes members Georgios Skiniotis and Ron Dror of Stanford University, Jian Jin of Icahn School of Medicine at Mt. Sinai, Brian Shoichet and Nevan Krogan of University of California at San Francisco and William Wetsel of Duke University.

SOURCE: https://www.marijuanamoment.net/military-invests-27m-to-develop-new-class-of-psychedelics-inspired-drugs/

Tags: , , , , , , , , ,
Posted in All Recent Posts, Mota Ventures Corp. | Comments Off on Military Invests $27M To Develop New Class Of Psychedelics Drugs SPONSOR: MOTA Ventures $MOTA.ca $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Affinity Metals $AFF.ca Acquires Five New Mineral Properties $MKR.ca $SII.ca $TUD.ca $GTT.ca $AMK.ca $OSK.ca $RKR.ca

Posted by AGORACOM at 3:03 PM on Thursday, June 25th, 2020

Vancouver, British Columbia–(Newsfile Corp. – June 25, 2020) – Affinity Metals Corp. (TSXV: AFF) (“the Corporation”) (“Affinity”) is pleased to report that it has acquired, through staking, five new mineral properties. Four of the properties are located near Timmins, Ontario, Canada and the fifth is located near Revelstoke, British Columbia, Canada. The Corporation is currently acquiring more detailed information and history on the properties and provided they continue to be seen as properties of merit will provide further background in a news release and on the Corporation’s website at www.affinity-metals.com.

About Affinity Metals

Affinity is focused on the acquisition, exploration and development of strategic metal deposits within North America. Affinity is following a Project Generator model.

In addition to these recent acquisitions, Affinity is advancing the Regal and West Timmins Gold Projects.

The Regal is located near Revelstoke, British Columbia, Canada in the northern end of the prolific Kootenay Arch and hosts two major geophysical anomalies as well as three past producing mines. Recent drill results included a new silver discovery with an 11.10 meter interval of 143.29 g/t silver which included a 0.55 meter interval of 2,612.0 g/t silver.

The West Timmins Gold property is located near Timmins, Ontario, Canada and adjoins Melkior’s Carscallen project. The first drill hole has been completed and the core is now being logged, split and sampled in preparation for assaying.

On behalf of the Board of Directors

Robert Edwards, CEO and Director of Affinity Metals Corp.

The Corporation can be contacted at: [email protected].

Information relating to the Corporation is available at: www.affinity-metals.com.

Tags: , , , , ,
Posted in Affinity Metals, All Recent Posts | Comments Off on Affinity Metals $AFF.ca Acquires Five New Mineral Properties $MKR.ca $SII.ca $TUD.ca $GTT.ca $AMK.ca $OSK.ca $RKR.ca

Datametrex $DM.ca Strengthens Board With Appointment of Benj Gallander

Posted by AGORACOM-JC at 2:30 PM on Thursday, June 25th, 2020
  • Announced the appointment of Mr. Benj Gallander as a new independent member of the Board of Directors
  • Benj has worked with start-ups and corporations of various sizes.
  • He has built his company over 25 years and understands the buy side in great detail, as well as corporate turnarounds
  • His background in investments greatly strengthens our company,” stated Marshall Gunter, CEO of Datametrex. “Benj is highly accomplished and connected within the investor community.”

TORONTO, June 25, 2020 – Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G, OTC: DTMXF) is pleased to announce the appointment of Mr. Benj Gallander as a new independent member of the Board of Directors.

“Benj has worked with start-ups and corporations of various sizes. He has built his company over 25 years and understands the buy side in great detail, as well as corporate turnarounds. His background in investments greatly strengthens our company,” stated Marshall Gunter, CEO of Datametrex. “Benj is highly accomplished and connected within the investor community.”

To support Datametrex’s growth, Mr. Gallander brings over 40 years of experience in the markets, with ample skills in integrating business and strategic investors and his know-how bringing innovation to companies.  Over time, he has refined his approach to investing and has achieved one of the best track records in the investment industry. Mr. Gallander is co-editor of Contra the Heard investment letter and over the past ten years the portfolio he manages achieved an annualized return of 18.4%. Benj co-writes “The Contra Guys” column for The Globe and Mail and is an author of three best-selling books, writes for several magazines, and has been a regular on BNN Bloomberg since virtually the beginning.

“Datametrex is poised to leverage their technology acumen and proven client solution capability. Datametrex’s recent initiative in COVID-19 testing kits has enabled the company to transform and breakthrough into society as a trusted and essential partner. I am looking forward to working with Marshall and the team at Datametrex,” said Benj. 

The company has issued Mr. Gallander 1,000,000 options at a strike price of C$0.10, being the closing price of the common shares of the Company on June 24, 2020.

As part of Board changes, Charles Schade is stepping down from the Board and will be joining the Company’s Advisory Board. Charles joined the company from the start and was the longest serving Board member.  The Company would like to thank Charles for his active contribution to the Board and looks forward to continuing to work with him as a member of the Advisory Board to the Company.

About Datametrex

Datametrex AI Limited is a technology focused company with exposure to Artificial Intelligence and Machine Learning through its wholly owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: , , , , , ,
Posted in Datametrex AI Limited, Featured | Comments Off on Datametrex $DM.ca Strengthens Board With Appointment of Benj Gallander

Spyder Cannabis $SPDR.ca Provides Corporate Update $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 12:26 PM on Thursday, June 25th, 2020

Vaughan, Ontario–(June 25, 2020) – Spyder Cannabis Inc. (TSXV: SPDR) (“Spyder” or the “Company“) provides an update to the filing extension as a result of COVID-19:

Filing Extension of Annual Disclosure Documents Due to COVID-19

Due to circumstances created by the COVID – 19 pandemic it will not be filing its audited financial statements and related management discussion and analysis for the fiscal year ended January 31, 2020 by the scheduled due date of June1, 2020, as required under section 4.4(b) and section 5.1(1) of National Instrument 51-102 – Continuous Disclosure Obligations (“NI 51-102”). Spyder will also not be filing its April 30, 2020 quarterly report and management discussion and analysis which is due June 29, 2020.

As required by Ontario Instrument 51-502 Temporary Exemption from Certain Corporate Finance Requirements (OSC Instrument 51-502), BC Instrument 51-515 Temporary Exemption from Certain Corporate Finance Requirements (BC Instrument 51-515), Blanket Order 51-517 Temporary Exemption from Certain Corporate Finance Requirements (ASC Blanket Order 51-517) and Manitoba Blanket Order 52-502 Temporary Exemption from Certain Corporate Finance Requirements (Manitoba Blanket Order 52-502), the Company discloses the following:

  • The Company’s management and other insiders will be subject to a trading black-out that reflects the principles in Section 9 of National Policy 11-207 – Failure-to-File Cease Trade Orders until its audited financial statements and related management discussion and analysis for the fiscal year ended January 31, 2020;
  • The Company expects to file its audited financial statements and related management discussion and analysis for the fiscal year ended January 31, 2020 on or about July 15, 2020 and the quarterly report along with the management discussion and analysis on or about July 31, 2020.

Summary of Recent Developments

On November 12, 2019, the company announced that it completed an acquisition of a development permit issued by the City of Calgary for the operation of a retail cannabis store.

In satisfaction of the purchase of $175,000 Spyder issued 3,000,000 common shares.

On December 20, 2019, the company announced that it’s previous announced Memorandum of Understanding with HighBreed Growth Corp. expired.

On December 23, 2019, the company announced that it had obtained two Development Permits in Calgary, Alberta and received one building permit for one of the locations. Additionally, the company will be submitting an application for a retail cannabis store in the province of Ontario.

On January 10, 2020, the company announced that it had issued 193,846 common shares in consideration for the provision of $12,600 in services provided by AGORA Internet Relations Corp..

On February 3, 2020, the company announced that it has cancelled the previously announced (January 13, 2020) non-brokered private placement of senior secured convertible debentures in the aggregate of $1,500,000. The company was abled to secure a secured bridge loan in the amount of $442,000 primarily by insiders and management.

On May 5, 2020, the company announced that it received a Conditional Cannabis Licence from the City of Alberta.

On May 12, 2020, the company announced that it had received a Cannabis Retail Operator’s Licence (“ROL”) for the Province of Ontario.

The company also previously announced that Mr. Ben Leung was appointed a new board member.

About Spyder Cannabis Inc.

Spyder is a Cannabis, Vape and CBD retailer that operates in jurisdictions where the products are federally legal in both Canada and the United States. The Company, through its subsidiaries, is a retailer involved in the development of three retail business units. The first is the sale of Cannabis products, the second is the sale of CBD in the United States only, the third is the sale of smoking cessation products in Ontario.

Cautionary Statements

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities laws (“forward-looking statements”). Forward- looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:

For more information, please contact:

Spyder Cannabis Inc.
Dan Pelchovitz
President & Chief Executive Officer
Telephone: 1.888.504.7737

Email: [email protected]

Tags: , , , , , ,
Posted in Spyder Cannabis Inc. | Comments Off on Spyder Cannabis $SPDR.ca Provides Corporate Update $CGC $ACB $APH $CRON.ca $OGI.ca

« Older Entries
Newer Entries »